NO180269C - Analogifremgangsmåte for fremstilling av terapeutisk akive aminoketonderivater - Google Patents

Analogifremgangsmåte for fremstilling av terapeutisk akive aminoketonderivater

Info

Publication number
NO180269C
NO180269C NO903430A NO903430A NO180269C NO 180269 C NO180269 C NO 180269C NO 903430 A NO903430 A NO 903430A NO 903430 A NO903430 A NO 903430A NO 180269 C NO180269 C NO 180269C
Authority
NO
Norway
Prior art keywords
preparation
therapeutically active
analogous process
aminoketone derivatives
active aminoketone
Prior art date
Application number
NO903430A
Other languages
English (en)
Other versions
NO180269B (no
NO903430L (no
NO903430D0 (no
Inventor
Akira Matsubara
Kazuya Sakai
Hideki Tanada
Akira Mizuchi
Kazutoshi Horikomi
Hideshi Shimizu
Original Assignee
Mitsui Toatsu Chemicals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsui Toatsu Chemicals filed Critical Mitsui Toatsu Chemicals
Publication of NO903430D0 publication Critical patent/NO903430D0/no
Publication of NO903430L publication Critical patent/NO903430L/no
Publication of NO180269B publication Critical patent/NO180269B/no
Publication of NO180269C publication Critical patent/NO180269C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
NO903430A 1989-08-04 1990-08-03 Analogifremgangsmåte for fremstilling av terapeutisk akive aminoketonderivater NO180269C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20141089 1989-08-04

Publications (4)

Publication Number Publication Date
NO903430D0 NO903430D0 (no) 1990-08-03
NO903430L NO903430L (no) 1991-02-05
NO180269B NO180269B (no) 1996-12-09
NO180269C true NO180269C (no) 1997-03-19

Family

ID=16440623

Family Applications (1)

Application Number Title Priority Date Filing Date
NO903430A NO180269C (no) 1989-08-04 1990-08-03 Analogifremgangsmåte for fremstilling av terapeutisk akive aminoketonderivater

Country Status (10)

Country Link
EP (1) EP0414391B1 (no)
JP (1) JPH0625178B2 (no)
KR (1) KR920009062B1 (no)
CN (1) CN1040105C (no)
AT (1) ATE119890T1 (no)
CA (1) CA2022462A1 (no)
DE (1) DE69017794T2 (no)
DK (1) DK0414391T3 (no)
FI (1) FI96856C (no)
NO (1) NO180269C (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5338857A (en) * 1989-08-04 1994-08-16 Mitsui Toatsu Chemicals Incorporated Aminoketone derivatives of 1,2-oxazole and use thereof
US5055585A (en) * 1990-02-08 1991-10-08 Mitsui Toatsu Chemicals, Incorporated Preparation process of aminoketones
US5194606A (en) * 1990-02-08 1993-03-16 Mitsui Toatsu Chemicals, Incorporated Preparation process of aminoketones
JP3164631B2 (ja) * 1991-02-26 2001-05-08 三井化学株式会社 光学活性アミノケトン誘導体及びその製造法
WO1996010567A1 (fr) * 1994-09-30 1996-04-11 Maruho Co., Ltd. Derive d'aminocetone et sel physiologiquement acceptable de celle-ci et leur utilisation
US5693804A (en) * 1994-11-17 1997-12-02 Molecular Geriatrics Corporation Substituted 1-aryl-3-piperazin-1'-yl propanones
US6214994B1 (en) 1997-04-21 2001-04-10 Molecular Geriatrics Corporation Certain substituted 1-aryl-3-piperazin-1′-yl propanones
DE10240026A1 (de) * 2002-08-27 2004-03-11 Merck Patent Gmbh Verfahren zur Herstellung von Monoalkylaminoketonen
JP3789465B1 (ja) 2005-04-28 2006-06-21 学校法人立教学院 イソオキサゾール誘導体又はジヒドロイソオキサゾール誘導体の製造方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE307581B (no) * 1963-07-31 1969-01-13 Shionogi & Co
JPS5862169A (ja) * 1981-10-09 1983-04-13 Nippon Kayaku Co Ltd 新規な5−アミノイソオキサゾ−ル誘導体
JPS58201770A (ja) * 1982-05-18 1983-11-24 Dainippon Pharmaceut Co Ltd α−置換−1,2−ベンズイソキサゾ−ル−3−酢酸エステル類並びにその酸付加塩類及び第4級アンモニウム塩類
JPS59181267A (ja) * 1983-03-30 1984-10-15 Nippon Kayaku Co Ltd 新規な5−メチルアミノ−3−置換フエニルイソオキサゾ−ル誘導体
AU4261285A (en) * 1984-06-01 1985-12-05 Tokyo Tanabe Company Limited 1-propanone derivatives
JPH0637389B2 (ja) * 1986-12-26 1994-05-18 北陸製薬株式会社 頻尿治療剤
US4980365A (en) * 1987-07-13 1990-12-25 Hoechst-Roussel Pharmaceuticals Inc. N-substituted-5,6-dimethoxy-1,2-benzisoxazole-3-propanamine and related compounds as analgesic and hypotensive agents
IE62276B1 (en) * 1988-03-30 1995-01-25 Sankyo Co "New isoxazole derivatives for use as cerebro-active drugs and central muscle relaxants"

Also Published As

Publication number Publication date
KR920009062B1 (ko) 1992-10-13
DK0414391T3 (da) 1995-04-03
NO180269B (no) 1996-12-09
ATE119890T1 (de) 1995-04-15
CN1040105C (zh) 1998-10-07
KR910004609A (ko) 1991-03-29
CA2022462A1 (en) 1991-02-05
JPH03157375A (ja) 1991-07-05
AU615621B2 (en) 1991-10-03
FI96856B (fi) 1996-05-31
CN1049660A (zh) 1991-03-06
NO903430L (no) 1991-02-05
JPH0625178B2 (ja) 1994-04-06
EP0414391A3 (en) 1991-07-17
DE69017794T2 (de) 1995-08-03
FI96856C (fi) 1996-09-10
FI903833A0 (fi) 1990-08-01
NO903430D0 (no) 1990-08-03
EP0414391A2 (en) 1991-02-27
AU5998790A (en) 1991-02-07
DE69017794D1 (de) 1995-04-20
EP0414391B1 (en) 1995-03-15

Similar Documents

Publication Publication Date Title
FI872864A0 (fi) Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi
FI881103A0 (fi) Menetelmä antidiabeettisena aineena käytettävien bensoksatsolijohdannaisten valmistamiseksi
FI893750A0 (fi) Menetelmä valmistaa terapeuttisesti aktiivista makrosyklistä johdannaista
PT87552A (pt) Process for the preparation of novel tetrazole intermediates toantihypertensive compounds
NO176356C (no) Analogifremgangsmåte for fremstilling av nye terapeutisk aktive pyrazolopyridinforbindelser
NO180719C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive A-nor-steroid-3-carboxylsyrederivater
NO890259D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive etylfenoksyacetamider.
NO892058L (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzamider.
GR900100380A (el) Μέ?οδος παρασκευής αντι-φλεγμονωδών παραγώγων αμινοφενόλης.
NO180269C (no) Analogifremgangsmåte for fremstilling av terapeutisk akive aminoketonderivater
PT84716A (en) Process for the preparation of insecticidal compositions containing six-membered heterocyclic derivatives of n:-substituted-n,n:-diacylhydrazines
PT84718A (en) Process for the preparation of insecticidal compositions containing five-membered heterocyclic derivatives of n:-substituted-n,n:-diacylhydrazines
NO167978C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrahydro-benzotiazoler.
DE68921051D1 (de) Pyridin-3-percarboxylsäure monopersulfat.
DE3883434D1 (de) Mitomycinanaloge, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitungen.
PT84635A (en) Process for the preparation of stable injectable compositions containing 4-amino-5-chloro-n-]2-(diethylamino) ethyl"-2-](substituted) alkoxy" benzamide antiemetic agents
PT73948A (en) Process for the preparation of biologically active heterobicyclic hydroximidates and thiolhydroximidates and carbamate ester derivatives thereof
ATE92037T1 (de) Kardiovaskulaer aktive verbindungen.
NO175099C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 1,3,5-tritianderivater
FR2395273A1 (fr) Derives de 7b-((2-amino-1,2-dioxoethyl)amino) acylcephalosporine et leur utilisation comme medicaments
FR2446817A1 (fr) Tetrahydro-2h-benzo(c)pyrroles, leur preparation et leur utilisation therapeutique